Immunomodulation by novel antimalarial chemotherapeutic agents.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000962:Antimalarials / Q000494:pharmacology*; D004912:Erythrocytes / Q000276:immunology; D006462:Hemolytic Plaque Technique; D006968:Hypersensitivity, Delayed; D007109:Immunity / Q000187:drug effects*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D010616:Phenanthrenes / Q000494:pharmacology; D014227:Triazines / Q000494:pharmacology
D000962:Antimalarials; D010616:Phenanthrenes; D014227:Triazines; C012496:alpha-(2-piperidyl)-3,6-bis(trifluoromethyl)-9-phenanthrenemethanol; C006201:BRL 6231